Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Kidney & Renal Pelvis (Late Stage^), 2016-2020

All Races (includes Hispanic), Female, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 2.9 (2.9, 3.0) N/A 6,093 25.6
Puerto Rico 6 1.2 (1.0, 1.4) N/A 27 21.1
District of Columbia 6 2.0 (1.5, 2.8) 49 (21, 49) 8 24.1
Hawaii 3 2.4 (2.0, 2.9) 48 (19, 49) 23 29.6
Virginia 6 2.4 (2.2, 2.6) 47 (35, 49) 131 23.2
New Hampshire 6 2.5 (2.0, 3.0) 46 (18, 49) 25 24.5
Florida 6 2.5 (2.4, 2.6) 45 (37, 49) 400 25.1
Colorado 6 2.5 (2.2, 2.7) 44 (27, 49) 82 24.7
Delaware 6 2.5 (2.0, 3.1) 43 (10, 49) 18 23.1
Arizona 6 2.6 (2.4, 2.8) 42 (26, 49) 120 24.6
Maryland 6 2.6 (2.4, 2.9) 41 (23, 48) 104 23.3
Utah 3 2.6 (2.3, 3.1) 40 (17, 49) 39 25.8
Alabama 6 2.7 (2.4, 2.9) 39 (21, 48) 89 21.4
South Carolina 6 2.7 (2.5, 3.0) 38 (20, 48) 97 23.3
California 3 2.7 (2.6, 2.8) 37 (26, 43) 645 27.3
Michigan 6 2.7 (2.6, 2.9) 36 (22, 45) 189 25.6
Connecticut 3 2.8 (2.5, 3.1) 35 (17, 48) 69 26.9
New York 3 2.8 (2.6, 2.9) 34 (23, 43) 365 25.6
New Jersey 3 2.8 (2.6, 3.0) 33 (21, 45) 169 27.0
Oregon 6 2.8 (2.5, 3.1) 32 (16, 47) 79 27.9
Massachusetts 3 2.8 (2.6, 3.0) 31 (19, 45) 131 27.7
Pennsylvania 6 2.8 (2.7, 3.0) 30 (20, 42) 263 25.9
Maine 6 2.9 (2.4, 3.4) 29 (7, 49) 30 26.6
Washington 5 2.9 (2.6, 3.1) 28 (17, 43) 134 27.6
Alaska 6 2.9 (2.2, 3.8) 27 (1, 49) 11 24.0
North Carolina 6 2.9 (2.8, 3.1) 26 (17, 40) 205 24.0
North Dakota 6 3.0 (2.3, 3.8) 25 (1, 49) 14 26.1
Idaho 3 3.0 (2.5, 3.5) 24 (4, 48) 33 25.8
Wyoming 6 3.1 (2.3, 4.0) 23 (1, 49) 12 29.6
Tennessee 6 3.1 (2.9, 3.3) 22 (9, 34) 141 22.7
Minnesota 6 3.1 (2.9, 3.4) 21 (8, 37) 112 28.6
Kansas 6 3.2 (2.8, 3.6) 20 (4, 41) 58 24.0
Georgia 3 3.2 (3.0, 3.4) 19 (8, 29) 204 26.8
Montana 6 3.2 (2.6, 3.9) 18 (1, 48) 23 29.4
Mississippi 6 3.3 (2.9, 3.6) 17 (3, 36) 64 21.2
Illinois 3 3.3 (3.1, 3.4) 16 (7, 25) 270 26.8
Nebraska 6 3.3 (2.8, 3.8) 15 (2, 41) 39 26.2
South Dakota 6 3.3 (2.6, 4.1) 14 (1, 48) 19 25.5
Ohio 6 3.3 (3.1, 3.5) 13 (6, 25) 263 26.8
Vermont 6 3.4 (2.6, 4.3) 12 (1, 48) 15 29.2
Wisconsin 6 3.4 (3.1, 3.7) 11 (4, 25) 132 28.3
Texas 3 3.4 (3.3, 3.6) 10 (5, 19) 541 24.7
Arkansas 6 3.4 (3.1, 3.8) 9 (1, 29) 67 21.8
Missouri 6 3.5 (3.2, 3.8) 8 (3, 22) 146 25.9
Kentucky 3 3.6 (3.3, 3.9) 7 (1, 21) 108 25.5
New Mexico 3 3.6 (3.1, 4.1) 6 (1, 28) 49 32.1
Iowa 3 3.7 (3.4, 4.1) 5 (1, 19) 82 29.2
Oklahoma 6 3.9 (3.5, 4.2) 4 (1, 14) 97 25.4
Rhode Island 6 3.9 (3.3, 4.6) 3 (1, 28) 28 35.1
West Virginia 6 3.9 (3.4, 4.5) 2 (1, 19) 52 26.2
Louisiana 3 3.9 (3.6, 4.3) 1 (1, 12) 119 25.4
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 06/29/2024 7:33 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top